BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 27895750)

  • 1. Expression of Circulating MicroRNA-141 in Epithelial Ovarian Cancer.
    Fitriawan AS; Kartika AI; Chasanah SN; Aryandono T; Haryana SM
    Malays J Med Sci; 2020 Dec; 27(6):27-38. PubMed ID: 33447132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular Vesicles-ceRNAs as Ovarian Cancer Biomarkers: Looking into circRNA-miRNA-mRNA Code.
    Cammarata G; Barraco N; Giusti I; Gristina V; Dolo V; Taverna S
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ROS and miRNA Dysregulation in Ovarian Cancer Development, Angiogenesis and Therapeutic Resistance.
    Stieg DC; Wang Y; Liu LZ; Jiang BH
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulated circular RNA hsa_circ_0005797 inhibits endometrial cancer by modulating microRNA-298/Catenin delta 1 signaling.
    Liu Y; Yuan H; He T
    Bioengineered; 2022 Mar; 13(3):4634-4645. PubMed ID: 34852711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP27B1 Downregulation: A New Molecular Mechanism Regulating EZH2 in Ovarian Cancer Tumorigenicity.
    Huo X; Sun H; Qian Q; Ma X; Peng P; Yu M; Zhang Y; Yang J; Cao D; Gui T; Shen K
    Front Cell Dev Biol; 2020; 8():561804. PubMed ID: 33163485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of CDK6 regulated by miR-298 on proliferation and apoptosis of thyroid cancer cells.
    Li X; Liu C; Zhao X; Wang R; Gu N; Shen H; Li X; Wang L; Li C
    Oncol Lett; 2020 Apr; 19(4):2909-2915. PubMed ID: 32218846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-153 regulated AKT1 expression and suppressed cell proliferation of epithelial ovarian cancer cells.
    Li W; Wang M; Meng B; Yu J; Chen Q; Li H; Liu Y
    Int J Clin Exp Pathol; 2017; 10(7):7417-7426. PubMed ID: 31966584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-298 reduces levels of human amyloid-β precursor protein (APP), β-site APP-converting enzyme 1 (BACE1) and specific tau protein moieties.
    Chopra N; Wang R; Maloney B; Nho K; Beck JS; Pourshafie N; Niculescu A; Saykin AJ; Rinaldi C; Counts SE; Lahiri DK
    Mol Psychiatry; 2021 Oct; 26(10):5636-5657. PubMed ID: 31942037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating microRNAs as novel potential diagnostic biomarkers for ovarian cancer: a systematic review and updated meta-analysis.
    Wang X; Kong D; Wang C; Ding X; Zhang L; Zhao M; Chen J; Xu X; Hu X; Yang J; Gao S
    J Ovarian Res; 2019 Mar; 12(1):24. PubMed ID: 30898156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA GAS6-AS2 promotes bladder cancer proliferation and metastasis via GAS6-AS2/miR-298/CDK9 axis.
    Rui X; Wang L; Pan H; Gu T; Shao S; Leng J
    J Cell Mol Med; 2019 Feb; 23(2):865-876. PubMed ID: 30394665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic Crosstalk between the Tumor Microenvironment and Ovarian Cancer Cells: A Therapeutic Road Less Traveled.
    Klymenko Y; Nephew KP
    Cancers (Basel); 2018 Aug; 10(9):. PubMed ID: 30200265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LINC01287/miR-298/STAT3 feedback loop regulates growth and the epithelial-to-mesenchymal transition phenotype in hepatocellular carcinoma cells.
    Mo Y; He L; Lai Z; Wan Z; Chen Q; Pan S; Li L; Li D; Huang J; Xue F; Che S
    J Exp Clin Cancer Res; 2018 Jul; 37(1):149. PubMed ID: 30001751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone Methyltransferase EZH2: A Therapeutic Target for Ovarian Cancer.
    Jones BA; Varambally S; Arend RC
    Mol Cancer Ther; 2018 Mar; 17(3):591-602. PubMed ID: 29726819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-205 regulates the proliferation and invasion of ovarian cancer cells via suppressing PTEN/SMAD4 expression.
    Chu P; Liang A; Jiang A; Zong L
    Oncol Lett; 2018 May; 15(5):7571-7578. PubMed ID: 29725462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatics analysis of RNA sequencing data reveals multiple key genes in uterine corpus endometrial carcinoma.
    Shen L; Liu M; Liu W; Cui J; Li C
    Oncol Lett; 2018 Jan; 15(1):205-212. PubMed ID: 29387216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EZH2 in Cancer Progression and Potential Application in Cancer Therapy: A Friend or Foe?
    Yan KS; Lin CY; Liao TW; Peng CM; Lee SC; Liu YJ; Chan WP; Chou RH
    Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28561778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-298 inhibits malignant phenotypes of epithelial ovarian cancer by regulating the expression of EZH2.
    Zhou F; Chen J; Wang H
    Oncol Lett; 2016 Nov; 12(5):3926-3932. PubMed ID: 27895750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-130b functions as a tumor suppressor by regulating RUNX3 in epithelial ovarian cancer.
    Paudel D; Zhou W; Ouyang Y; Dong S; Huang Q; Giri R; Wang J; Tong X
    Gene; 2016 Jul; 586(1):48-55. PubMed ID: 27048832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-205 promotes motility of ovarian cancer cells via targeting ZEB1.
    Niu K; Shen W; Zhang Y; Zhao Y; Lu Y
    Gene; 2015 Dec; 574(2):330-6. PubMed ID: 26275944
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.